Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma
NCT06948552Phase 2Recruiting
- Sponsor
- Henry Ford Health
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in upper tract urothelial carcinoma (UTUC), sponsored by Henry Ford Health. Started Sep 2026; status: recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT06948552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06948552.